Literature DB >> 24905522

Mortality in hypertensive patients with coronary heart disease depends on chronopharmacotherapy and dipping status.

Wojciech Sobiczewski1, Marcin Wirtwein2, Marcin Gruchała1, Ivan Kocić3.   

Abstract

BACKGROUND: The goal of our study was to assess the influence of hypertension chronopharmacotherapy on diurnal blood pressure (BP) profile and mortality.
METHODS: Subjects with established coronary heart disease (CHD) (n = 1345, mean age 63.2 ± 9.2 years) were included.
RESULTS: Non-dipping status was related to a lack of nighttime hypertensive drug administration (OR 3.87, 95% CI 3.00-4.98). In a Cox proportional hazards regression model, non-dipping status (HR 1.17, 95% CI 1.02-1.47) and non-nighttime antihypertensive drug administration (HR 1.13, 95% CI 1.01-1.45) were predictors of all-cause mortality.
CONCLUSIONS: The non-dipping profile of CHD patients and increased mortality were related to a lack of antihypertensive drug administration at bedtime.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Blood pressure profile; Chronopharmacotherapy; Coronary heart disease; Hypertension; Non-dippers

Mesh:

Substances:

Year:  2014        PMID: 24905522     DOI: 10.1016/j.pharep.2013.12.009

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.

Authors:  Ramón C Hermida; Michael H Smolensky; Horia Balan; Richard J Castriotta; Juan J Crespo; Yaron Dagan; Sherine El-Toukhy; José R Fernández; Garret A FitzGerald; Akio Fujimura; Yong-Jian Geng; Ramón G Hermida-Ayala; Antonio P Machado; Luiz Menna-Barreto; Artemio Mojón; Alfonso Otero; R Daniel Rudic; Eva Schernhammer; Carsten Skarke; Tomoko Y Steen; Martin E Young; Xiaoyun Zhao
Journal:  Chronobiol Int       Date:  2020-12-20       Impact factor: 3.749

Review 2.  An Overview of the Circadian Clock in the Frame of Chronotherapy: From Bench to Bedside.

Authors:  Alan Vandenberghe; Marc Lefranc; Alessandro Furlan
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.